BioSpace News Archive

Drug Development

CG Oncology’s Bladder Cancer Therapy Impresses at AACR

CG Oncology presented positive interim Phase II results for its Core1 trial studying the use of CG0070 at the American Association for Cancer Research (AACR) Annual Meeting.

April 15, 2022
·
2 min read
·
Jazmine Colatriano, M.S.
Drug Development

Multiple Sclerosis Economic Burden hits $85 Billion as Treatments Advance

There are an estimated 2.3 million people living with Multiple Sclerosis and hundreds of thousands more undiagnosed, adding up to an annual cost of nearly $85 billion for care in the United States.

April 15, 2022
·
3 min read
·
Alex Keown
Drug Development

Allogene Accelerates Manufacturing Capacity for Upcoming Pivotal Trial

The new facility is expected to bolster innovation across all facets of manufacturing to allow the company to fully develop and commercialize cancer treatments for patients in need.

April 15, 2022
·
2 min read
·
Alex Keown
Career Advice

A Complete Guide to the Biopharma Job Search

The search for a biopharma job can be daunting, but it doesn’t have to be. Here is a complete guide to the biopharma job hunt, from researching job openings to writing resumes and cover letters.

April 15, 2022
·
5 min read
·
Franklin Carpenter
Drug Development

AACR: Advances in Immune System Stimulation and Cell Transplants Favor Oncology

BioSpace looked at some of the efforts to improve the host system’s immune response, as well as others to improve allogeneic or autologous cell transplants.

April 15, 2022
·
6 min read
·
Gail Dutton
Policy

12 Chinese Companies Face Potential Wall Street Delisting

The SEC added 12 China companies to their delisting watchlist this week. The companies will need to release evidence by May 3 to remain listed.

April 15, 2022
·
3 min read
·
Mark Terry
FDA

FDA Grants EUA for COVID-19 Breathalyzer

The U.S.Food and Drug Administration has granted Emergency Use Authorization to a breathalyzer that can detect COVID-19 within three minutes.

April 15, 2022
·
2 min read
·
Vanessa Doctor, RN
Policy

McKinsey & Co. Under Fire for Allegedly Advising Purdue and FDA Concurrently

McKinsey & Company is under fire for allegedly allowing its employees to work simultaneously for big pharma companies and serve as consultants for the U.S. Food and Drug Administration.

April 15, 2022
·
3 min read
·
Hayley Shasteen
Business

BMS and Nektar Shutter Combination Cancer Development Program

Bristol Myers Squibb and Nektar Therapeutics ended their global clinical program for potential bladder cancer and renal cell carcinoma treatment.

April 15, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

TG Therapeutics Backpedals on BLA for Lymphoma, Leukemia Treatment

TG Therapeutics voluntarily withdrew its pending BLA and supplemental NDA for its treatment dubbed U2 for adults with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

April 15, 2022
·
3 min read
·
Mark Terry